
Teva will get US commercialisation rights for Eticovo upon close and infliximab in Q3 2027

The agreement gives Fresenius exclusive option rights for up to 37 potential first-to-market biosimilar candidates

The agreement for up to ten biosimilar assets represents one of largest ever biosimilar collaborations for the company

The report forecasts a rise in cases in the US, the UK, Canada, Australia and Europe

The agreement will expand the pipeline and builds on an existing partnership

The investment is expected to generate up to 750 new jobs

An estimated 32 million people aged 50 years and over in Europe were living with osteoporosis in 2019

The drug is approved for inflammatory conditions such as Crohn's disease and plaque psoriasis

The drug has been approved to treat plaque psoriasis, psoriatic arthritis and Crohn’s disease

The commitment is part of the company’s ambition to achieve $80bn in total revenue by 2030

The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) will be hosting European Laboratory Day, on November 05th 2024. This annual event celebrates the contributions of laboratory medicine professionals...

The drug has been authorised for use in gastroenterology, dermatology and rheumatology indications